Pathophysiological importance of various molecular forms of human choriogonadotropin

Molecular and Cellular Endocrinology

Volumn 125, Issue 1-2, 1996, Pages 107-120

  Alfthan, Henrik ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Choriogonadotropin; Fragment; hCG; Immunoassay; Subunit

Indexed keywords

CHORIONIC GONADOTROPIN; PROTEIN SUBUNIT;

CONFERENCE PAPER; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE STRUCTURE; HORMONE URINE LEVEL; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STANDARDIZATION;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TESTS;

EID: 0030596014     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03941-X     Document Type: Conference Paper

References (172)

1. [1] Stenman, U.-H., Bidart, J.-M., Birken, S., Mann, K., Nisula, B. and O'Connor, J. (1993) Standardization of protein immunoprocedures. Choriogonadotropin (CG). Scand. J. Clin. Lab. Invest. 53, 42-78.
2. [2] Yoshimi, T., Strott, C.A., Marshall, J.R. and Lipsett, M.B. (1969) Corpus luteum function in early pregnancy. J. Clin. Endocrinol. Metab. 29, 225-230.
3. [3] Huhtaniemi, I.T., Korenbrot, C.C. and Jaffe, R.B. (1977) hCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J. Clin. Endocrinol. Metab. 44, 963-967.
4. [4] Rayford, P.L., Vaitukaitis, J.L., Ross, G.T., Morgan, F.J. and Canfield, R.E. (1972) Use of specific antisera to characterize biologic activity of hCGβ subunit preparations. Endocrinology 91, 144-146.
5. [5] Catt, K.J., Dufau, M.L. and Tsuruhara, T. (1973) Absence of intrinsic biological activity in LH and hCG subunits. J. Clin. Endocrinol. Metab. 36, 73-80.
6. [6] Blithe, D.L., Richards, R.G. and Skarulis, M.C. (1991) Free alpha molecules from pregnancy stimulate secretion of prolactin from human decidual cells: a novel function for free alpha in pregnancy. Endocrinology 129, 2257-2259.
7. [7] Moy, E., Kimzey, L.M., Nelson, L.M and Blithe, D.L. (1996) Glycoprotein hormone α-subunit functions synergistically with progesterone to stimulate differentiation of cultured human endometrial stromal cells to decidualized cells: a vovel role for free α-subunit in reproduction. Endocrinology 137, 1332-1339.
8. [8] Rivera, R.T., Pasion, S.G., Wong, D.T.W., Fei, Y. and Biswas, D.K. (1989) Loss of tumorigenic potential by human lung tumor cells in the presence of antisense RNA specific to the ectopically synthesized alpha subunit of human chorionic gonadotropin. J. Cell Biol. 108, 2423-2434.
9. [9] Ronco, A.M., Llanos, M.N. and Valladares, L.E. (1993) Human chorionic gonadotropin and free subunits stimulate phospholipid methylation in intact rat Leydig cells. Steroids 58, 314-319.
10. [10] Gillott, D.J., Iles, R.K. and Chard, T. (1996) The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br. J. Cancer 73, 323-326.
11. [11] Yazaki, K., Yazaki, C., Wakabayashi, K. and Igarashi, M. (1980) Isoelectric heterogeneity of human chorionic gonadotropin: Presence of choriocarcinoma specific components. Am. J. Obstet. Gynecol. 138, 189-194.
12. [12] Cassels, J.W., Mann, K., Blithe, D.L., Nisula, B.C. and Wehmann, R.E. (1989) Reduced metabolic clearance of acidic variants of human choriogonadotropin from patients with testicular cancer. Cancer 64, 2313-2318.
13. [13] Mizuochi, T., Nishimura, R. and Derappe (1983) Structures of the asparagine-linked sugar chains of human chorionic gonadotropin produced in choriocarcinoma. Appearance of triantennary sugar chains and unique biantennary sugar chains. J. Biol. Chem. 258, 14126.
14. [14] Imamura, S., Armstrong, E.G., Birken, S., Cole, L.A. and Canfield, R.E. (1987) Detection of desialylated forms of human chorionic gonadotropin. Clin. Chim. Acta 163, 339-349.
15. [15] Endo, T., Nishimura, R., Teshima, S.-I., Ohkura, H., Baba, S. and Kobata, A. (1991) Structures of the asparagine-linked sugar chains of human chorionic gonadotropin from a patient with extragonadal germ cell tumor. Eur. J. Cancer 27, 277-280.
16. [16] Cole, L.A., Hartle, R.J., Laferla, J.J. and Ruddon, R.W. (1983) Detection of free beta subunit of human chorionic gonadotropin (hCG) in cultures of normal and malignant trophoblastic cells, pregnancy sera, and sera of patients with choriocarcinoma. Endocrinology 113, 1176-1178.
17. [17] Thotakura, N.R. and Bahl, O.P. (1986) Purification and properties of a monoclonal antibody specific to the free β-subunit of human chorionic gonadotropin (hCGβ) and its use in the isolation of free hCGβ produced by choriocarcinoma cells. Endocrinology 119, 1887-1894.
18. [18] Beebe, J.S., Huth, J.R. and Ruddon, R.W. (1990) Combination of the chorionic gonadotropin free β-subunit with α. Endocrinology 126, 384-391.
19. [19] Nagelberg, S.B., Marmorstein, B., Khazaeli, M.B. and Rosen, S.W. (1985) Isolated ectopic production of the free beta subunit of chorionic gonadotropin by an epidermoid carcinoma of unknown site. Cancer 55, 1924-1930.
20. [20] Hussa, R.O., Fein, H.G., Pattillo, R.A., Nagelberg, S.B., Rosen, S.W., Weintraub, B.D., Perini, F., Ruddon, R.W. and Cole, L.A. (1986) A distinctive form of human chorionic gonadotropin β-subunit-like material produced by cervical carcinoma cells. Cancer Res. 46, 1948-1954.
21. [21] Cole, L.A. and Hussa, R.O. (1981) Use of glycosidase digested human chorionic gonadotropin β-subunit to explain the partial binding of ectopic glycoprotein hormones to con A. Endocrinology 109, 2276-2278.
22. [22] Weintraub, B.D., Krauth, G., Rosen, S.W. and Rabson, A.S. (1975) Differences between purified ectopic and normal alpha subunits of human glycoprotein hormones. J. Clin. Invest. 56, 1043-1052.
23. [23] Fein, J.L., Rosen, S.W. and Weintraub, B.D. (1980) Increased glycosylation of serum human chorionic gonadotropin and subunits from eutopic and ectopic sources: Comparison with urinary and placental forms. J. Clin. Endocrinol. Metab. 50, 1111-1120.
24. [24] Blithe, D.L. and Nisula, B.C. (1985) Variations in the oligosaccharides of free and combined α-subunits of human choriogonadotropin in pregnancy. Endocrinology 117, 2218-2228.
25. [25] Matthies, D.L. and Diczfalusy, E. (1971) Relationships between physicochemical, immunological and biological properties of human chorionic gonadotrophin. 1. Properties of human chorionic gonadotrophin as found in tissues and body fluids. Acta Endocrinol. (Copenhagen) 67, 434-444.
26. [26] Franchimont, P., Gaspard, U., Reuter, A. and Heynen, G. (1972) Polymorphism of protein and polypeptide hormones. Clin. Endocrinol. (Oxford) 11, 315-336.
27. [27] Vaitukaitis, J.L. (1973) Immunological and physiological characterization of human chorionic gonadotropin (hCG) secreted by tumors. J. Clin. Endocrinol. Metab. 37, 505-514.
28. [28] Birken, S., Armstrong, E.G., Kolks, M.A.G., Cole, L.A., Agosto, G.M., Krichevsky, A., Vaitukaitis, J.L. and Canfield, R.E. (1988) Structure of the human chorionic gonadotropin β-subunit fragment from pregnancy urine. Endocrinology 123, 572-583.
29. [29] Blithe, D.L., Akar, A.H., Wehmann, R.E. and Nisula, B.C. (1988) Purification of β-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-β. Endocrinology 122, 173-180.
30. [30] Bidart, J.-M., Puisieux, A., Troalen, F., Foglietti, M.J., Bouhon, C. and Bellet, D. (1988) Characterization of a cleavage product in the human choriogonadotropin β-subunit. Biochem. Biophys. Res. Commun. 154, 626-632.
31. [31] Nishimura, R., Ide, K., Utsunomiya, T., Kitajima, T., Yuki, Y. and Mochizuki, M. (1988) Fragmentation of the β-subunit of human chorionic gonadotropin produced by choriocarcinoma. Endocrinology 123, 420-425.
32. [32] Puisieux, A., Bellet, D., Troalen, F., Razafindratsita, A., Lhomme, C., Bohuon, C. and Bidart, J.-M. (1990) Occurence of fragmentation of free and combined forms of the β-subunit of human chorionic gonadotropin. Endocrinology 126, 687-694.
33. [33] Sakakibara, R., Miyazaki, S. and Ishiguro, M. (1990) A nicked β-subunit of human chorionic gonadotropin purified from pregnancy urine. J. Biochem. 107, 858-862.
34. [34] Cole, L.A., Kardana, A., Park, S.-Y. and Braunstein, G.D. (1993) The deactivation of hCG by nicking and dissociation. J. Clin. Endocrinol. Metab. 76, 704-710.
35. [35] Strickland, T.W. and Puett, D. (1982) The kinetic and equilibrium parameters of subunit association and gonadotorpin dissociation. J. Biol. Chem. 257, 2954-2960.
36. [36] Cole, L.A., Kardana, A., Andrade, G.P., Gawinowicz, M.A., Morris, J.C., Bergert, E.R., O'Connor, J. and Birken, S. (1991) The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology 129, 1559-1567.
37. [37] Birken, S., Gawinowicz, M.A., Kardana, A. and Cole, L.A. (1991) The heterogeneity of human chorionic gonadotropin (hCG). II. Characteristics and origins of nicks in hCG reference standards. Endocrinology 129, 1551-1558.
38. [38] Wide, L., Johannisson, E., Tillinger, K.-G. and Diczfalusy, E. (1968) Metabolic clearance of human chorionic gonadotrophin administered to non pregnant women. Acta Endocrinol. (Copenhagen) 59, 579-594.
39. [39] Rizkallah, T., Gurpide, E. and Wiele, R.L.V. (1969) Metabolism of hCG in man. J. Clin. Endocrinol. 29, 92-100.
40. [40] Wehmann, R.E. and Nisula, B.C. (1981) Metabolic and renal clearance rates of purified human chorionic gonadotropin. J. Clin. Invest. 38, 184-194.
41. [41] Blithe, D.L. and Nisula, B.C. (1987) Similarity of the clearance rates of free α-subunit and α-subunit dissociated from intact human chorionic gonadotropin, despite differences in sialic acid contents. Endocrinology 121, 1215-1220.
42. [42] Masure, H.R., Jaffee, W.L., Sickel, M.A., Birken, S., Canfield, R.E. and Vaitukaitis, J.L. (1981) Characterization of a small molecular size urinary immunoreactive human chorionic gonadotropin (hCG) like substance produced by normal placenta and by hCG-secreting neoplasms. J. Clin. Endocrinol. Metab. 53, 1014-1020.
43. [43] Wehmann, R.E., Blithe, D.L., Flack, M.R. and Nisula, B.C. (1989) Metabolic clearance rate and urinary clearance of purified β-core. J. Clin. Endocrinol. Metab. 69, 510-517.
44. [44] Marshall, J.R., Hammond, C.B., Ross, G.T., Jacobson, A., Rayford, P. and Odell, W.D. (1968) Plasma and urinary chorionic gonadotropin during early human pregnancy. Obstet. Gynecol. 32, 760-764.
45. [45] Braunstein, G.D., Vaitukaitis, J.L. and Ross, G.T. (1972) The in vivo behavior of human chorionic gonadotropin after dissociation into subunits. Endocrinology 91, 1030-1036.
46. [46] Tsuruhara, T., van Hall, E.V., Dufau, M.L. and Catt, K.J. (1972) Ovarian binding of intact and desialylated hCG in vivo and in vitro. Endocrinology 91, 463-469.
47. 125I]iodochorionic gonadotropin from the circulation in thye rat: tissue uptake and degradation. Endocrinology 104, 1540-1547.
48. [48] Wehmann, R.E. and Nisula, B.C. (1980) Characterization of a discrete degradation product of human chorionic gonadotropin β-subunit in humans. J. Clin. Endocrinol. Metab. 51, 101-105.
49. [49] Alfthan, H., Schröder, J., Fraser, R., Koskimies, A., Halila, H. and Stenman, U.-H. (1988) Choriogonadotropin and its β subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin. Chem. (NY) 34, 1758-1762.
50. [50] Canfield, R.E. and Ross, G.T. (1976) A new reference preparation of human chorionic gonadotropin and its subunits. Bull. WHO 54, 436-470.
51. [51] Storring, P.L., Gaines-Das, R.E. and Bangham, D.R. (1980) International reference preparation of human chorionic gonadotrophin for immunoassay: Potency estimates in various bioassay and protein binding assay systems; and international reference preparations of α and β subunits of human chorionic gonadotrophin for immunoassay. J. Endocrinol. 84, 295-310.
52. [52] Wehmann, R.E., Blithe, D.L., Akar, A.H. and Nisula, B.C. (1988) β-core fragments are contaminants of the World Health Organization reference preparations of human choriogonadotropin and its α-subunit. J. Endocrinol. 117, 147-152.
53. [53] Cole, L.A. and Kardana, A. (1992) Discordant results in human chorionic gonadotropin assays. Clin. Chem. 38, 263-270.
54. [54] Kardana, A., Bagshawe, K.D., Coles, B., Read, D. and Taylor, M. (1993) Characterisation of UGP and its relationship with beta-core fragment. Br. J. Cancer 67, 686-692.
55. [55] Cole, L.A., Schwartz, P.E. and Wang, Y. (1988) Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers. Gynecol. Oncol. 31, 82-90.
56. [56] Krichevsky, A., Armstrong, E.G., Schlatterer, J., Birken, S., O'Connor, J., Bikel, K., Silverberg, S., Lustbader, J.W. and Canfield, R.E. (1988) Preparation and characterization of antibodies to the urinary fragment of the human chorionic gonadotropin β-subunit. Endocrinology 123, 584-593.
57. [57] Krichevsky, A., Birken, S., O'Connor, J., Bikel, K., Schlatterer, J., Yi, C., Agosto, G. and Canfield, R.E. (1991) Development and characterization of a new, highly specific antibody to the human chorionic gonadotropin-β fragment. Endocrinology 128, 1255-1264.
58. [58] Lenton, E.A., Neal L.M. and Sulaiman, R. (1982) Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancy. Fertil. Steril. 37, 773-778.
59. [59] Pittaway, D.E., Reish, R.L. and Wentz, A.C. (1986) Doubling times of human chorionic gonadotropin increase in early viable intrauterine pregnancies. Am. J. Obstet. Gynecol. 152, 299-302.
60. [60] Braunstein, G.D., Rasor, J., Adler, D., Danzer, H. and Wade, M.E. (1976) Serum human chorionic gonadotropin levels throughout normal pregnancy. Am. J. Obstet. Gynecol. 15, 678-681.
61. [61] Saxena, B.B. and Rathnam, P. (1978) The structure and function of follicle- stimulating hormone. In: Structure and Function of the Gonadotropins (McKearns, K.W., ed.), pp. 183-212, Plenum Press, New York.
62. [62] Reuter, A.M., Gaspard, U.J., Deville, J.-L., Vrindts-Gevaert, Y. and Franchimont, P. (1980) Serum concentrations of human chorionic gonadotrophin and its alpha and beta subunits. 1. During normal singleton and twin pregnancies. Clin. Endocrinol. (NY) 13, 305-318.
63. [63] Pastorfide, G.B., Goldstein, D.P., Kosasa, T.S. and Levesque, L. (1974) Serum chorionic gonadotropin activity after molar pregnancy, therapeutic abortion, and term delivery. Am. J. Obstet. Gynecol. 118, 293-294.
64. [64] Ozturk, M., Bellet, D., Manil, L., Hennen, G., Frydman, R. and Wands, J. (1987) Physiological studies of human chorionic gonadotropin (hCG), αhCG and βhCG as measured by specific monoclonal immunoradiometric assays. Endocrinology 120, 549-558.
65. [65] Benveniste, R. and Scommegna, A. (1981) Human chorionic gonadotropin α-subunit in pregnancy. Am. J. Obstet. Gynecol. 141, 952-961.
66. [66] Rutanen, E.-M. (1978) The circulating alpha subunit of human chorionic gonadotrophin in gynaecologic tumors. Int. J. Cancer 22, 413-421.
67. [67] Alfthan, H. and Stenman, U.-H. (1990) Pregnancy serum contains the β-core fragment of human choriogonadotropin. J. Clin. Endocrinol. Metab. 70, 783-787.
68. [68] Wehmann, R.E., Blithe, D.L., Akar, A.H. and Nisula, B.C. (1990) Disparity between β-core levels in pregnancy urine and serum: Implications for the origin of urinary β-core. J. Clin. Endocrinol. Metab. 70, 371-378.
69. [69] Kardana, A. and Cole, L.A. (1990) Serum hCG β-core fragment is masked by associated macromolecules. J. Clin. Endocrinol. Metab. 71, 1393-1395.
70. [70] de Medeiros, S.F., Amato, F., Bacich, D., Wang, L., Matthews, C.D. and Norman, R.J. (1992) Distribution of the β-core human chorionic gonadotrophin fragment in human body fluids. J. Endocrinol. 135, 175-188.
71. [71] Birken, S., Chen, Y., Gawinowicz, M.A., Agosto, G.M., Canfield, R.E. and Hartree, A.S. (1993) Structure and significance of human luteinizing hormone-β core fragment purified from human pituitary extracts. Endocrinology 133, 985-989.
72. [72] Cole, L.A. and Birken, S. (1988) Origin and occurrence of human chorionic gonadotropin β-subunit core fragment. Mol. Endocrinol. 2, 826-830.
73. [73] Schroeder, H.R. and Halter, C.M. (1983) Specificity of human β- choriogonadotropin assays for the hormone and for an immunoreactive fragment present in the urine during normal pregnancy. Clin. Chem. 29, 667-671.
74. [74] Kato, Y. and Braunstein, G.D. (1988) β-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy. J. Clin. Endocrinol. Metab. 66, 1197-1201.
75. [75] de Medeiros, S.F., Amato, F., Matthews, C.D. and Norman, R.J. (1992) Urinary concentrations of beta core fragment of hCG throughout pregnancy. Obstet. Gynecol. 80, 223-228.
76. [76] Cole, L.A., Seifer, D.B., Kardana, A. and Braunstein, G.D. (1993) Selecting human chorionic gonadotropin immunoassays: consideration of crossreacting molecules in first-trimester pregnancy serum and urine. Am. J. Obstet. Gynecol. 168, 1580-1586.
77. [77] McCready, J., Braunstein, G.D., Helm, D. and Wade, M.E. (1978) Modification of the choriogonadotropin beta-subunit radioimmunoassay for determination of urinary choriogonadotropin. Clin. Chem. 24, 1958-1961.
78. [78] Norman, R.J., Buck, R.H., Rom, L. and Joubert, S.M. (1988) Blood or urine measurement of human chorionic gonadotropin for detection of ectopic pregnancy? A comparative study of quantitative and qualitative methods in both fluids. Obstet. Gynecol. 71, 315-318.
79. [79] Norman, R.J., Haneef, R., Buck, R.H. and Joubert, S.M. (1987) Measurement of the free alpha subunit of human glycoprotein hormones by a monoclonal antibody-based immunoradiometric assay, and further exploration of antigenic sites on the choriogonadotropin molecule. Clin. Chem. 33, 1147-1151.
80. [80] Kletzky, O.A., Rossman, F., Bertolli, S.I., Platt, L.D. and Mishell, D.R. (1985) Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancy. Am. J. Obstet. Gynecol. 151, 878-884.
81. [81] Ozturk, M., Brown, N., Milunsky, A. and Wands, J. (1988) Physiological studies of human chorionic gonadotropin and free subunits in the amniotic fluid compartment compared to those in maternal serum. J. Clin. Endocrinol. Metab. 67, 1117-1121.
82. [82] Jouppila, P., Tapanainen, J. and Huhtaniemi, I. (1979) Plasma hCG levels in patients with bleeding in the first and second trimesters of pregnancy. Br. J. Obstet. Gynaecol. 86, 343-349.
83. [83] Wilcox, A.J., Weinberg, C.R., O'Connor, J.F., Baird, D.D., Schlatterer, J.P., Canfield, R.E., Armstrong, E.G. and Nisula, B.C. (1988) Incidence of early pregnancy loss. N. Engl. J. Med. 319, 189-194.
84. [84] Edmonds, D.K., Lindsay, K.S., Miller, J.F., Williamson, E. and Wood, P.J. (1982) Early embryonic mortality in women. Fertil. Steril. 38, 447-453.
85. [85] Braunstein, G.D., Karow, W.G., Gentry, W.C., Rasor, J. and Wade, M.E. (1978) First-trimester chorionic gonadotropin measurements as an aid in the diagnosis of early pregnancy disorders. Am. J. Obstet. Gynecol. 131, 25-32.
86. [86] Kadar, N., DeCherney, A.H. and Romero, R. (1982) Receiver operating characteristic (ROC) curve analysis of the relative efficacy of single and serial chorionic gonadotropin determinations in the early diagnosis of ectopic pregnancy. Fertil. Steril. 37, 542-547.
87. [87] Cacciatore, B., Stenman, U.-H. and Ylöstalo, P. (1990) Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination with a discriminatory serum hCG level of 1000 IU/1 (IRP). Br. J. Obstet. Gynaecol. 97, 904-908.
88. [88] Cacciatore, B., Stenman, U.H. and Ylöstalo, P. (1994) Early screening for ectopic pregnancy in high-risk symptom-free women. Lancet 343, 517-518.
89. [89] L'Hermite-Balériaux, M., van Exter, C., Deville, J.L., Gaspard, U. and Hechtermans, R. (1982) Alteration of free hCG subunits secretion in ectopic pregnancy. Acta Endocrinol. (Copenhagen) 100, 109-113.
90. [90] Barnea, E.R., Oelsner, G., Benveniste, R., Romero, R. and DeCherney, A.H. (1986) Progesterone, estradiol, and α-human chorionic gonadotropin secretion in patients with ectopic pregnancy. J. Clin. Endocrinol. Metab. 62, 529-531.
91. [91] Bogart, M.H., Pandiani, M.R. and Jones, O.W. (1988) Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetasl chromosome abnormalities. Prenatal Diagn. 7, 623-630.
92. [92] Wald, N.J., Cuckle, H.S., Densem, J.W., Nanchahal, K., Royston, P., Chard, T., Haddow, J.E., Knight, G.J., Palomaki, G.E. and Canick, J.A. (1988) Maternal serum screening for Down's syndrome in early pregnancy. Br. Med. J. 297, 883-887.
93. [93] Macri, J.N., Kasturi, R.V., Krantz, D.A., Cook, E.J., Moore, N.D., Young, J.A., Romero, K. and Larsen, J.W.J. (1990) Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin. Am. J. Obstet. Gynecol. 163, 1248-1253.
94. [94] Spencer, K. (1991) Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome. Clin. Chem. 37, 809-814.
95. [95] Pettersson, K., Alfthan, H., Stenman, U.-H., Turpeinen, U., Suonpää, M., Söderholm, J., Olesen Larsen, S. and Nørgaard-Pedersen, B. (1993) Simultaneous dual-label assay of alpha-fetoprotein and the free beta subunit of human chorionic gonadotropin by time-resolved detection of fluorescent europium and samarium chelates. Clin. Chem. 39, 2084-2089.
96. [96] Nørgaard-Pedersen, B., Alfthan, H., Arends, J., Høgdall, C.K., Larsen. S.O., Pettersson, K., Stenman, U.-H. and Salonen, R. (1994) A new simple and rapid dual assay for AFP and hCG in screening for Down's syndrome. Clin. Genet. 45, 1-4.
97. [97] Braunstein, G.D., Rasor, J. and Wade, M.E. (1975) Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone. N. Engl. J. Med. 293, 1339-1343.
98. [98] Yoshimoto, Y., Wolfsen, A.R. and Odell, W.D. (1977) Human chorionic gonadotropin-like substance in nonendocrine tissues of normal subjects. Science 197, 575-577.
99. [99] Braunstein, G.D., Kamdar, V., Rasor, J., Swaminathan, N. and Wade, M.E. (1979) Widespread distribution of a chorionic gonadotropin-like substance in normal human tissues. J. Clin. Endocrinol. Metab. 49, 917-925.
100. [100] Hartree, A.S., Shownkeen, R.C., Stevens, V.C., Matsuura, S., Ohashi, M. and Chen, H.-C. (1983) Studies of the human chorionic gonadotrophin-like substance of human pituitary glands and its significance. J. Endocrinol. 96, 115-126.
101. [101] Hoermann, R., Spoettl, G., Moncayo, R. and Mann, K. (1990) Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary. J. Clin. Endocrinol. Metab. 71, 179-186.
102. [102] van Strien, A. and van Wezenbeek, P. (1989) Prescence of βhCG mRNA in the human pituitary. Nucleic Acids Res. 17, 5406.
103. [103] Vaitukaitis, J.L., Braunstein, G.D. and Ross, G.T. (1972) A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am. J. Obstet. Gynecol. 113, 751-758.
104. [104] Borkowski, A. and Muquardt, C. (1979) Human chorionic gonadotropin in the plasma of normal nonpregnant subjects. N. Engl. J. Med. 301, 298-302.
105. [105] Stenman, U.-H., Alfthan, H., Ranta, T., Vartiainen, E., Jalkanen, J. and Seppälä, M. (1987) Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin releasing hormone and sex steroids. J. Clin. Endocrinol. Metab. 64, 730-736.
106. [106] Odell, W.D. and Griffin, J. (1987) Pulsatile secretion of human chorionic gonadotropin in normal adults. N. Engl. J. Med. 317, 1688-1691.
107. [107] Alfthan, H., Haglund, C., Dabek, J. and Stenman, U.-H. (1992) Concentrations of hCG, βhCG and cβhCG in serum and urine of nonpregnant women and men. Clin. Chem. 38, 1981-1987.
108. [108] Madersbacher, S., Klieber, R., Mann, K., Marth, C., Tabarelli, M., Wick, G. and Berger, P. (1992) Free α-subunit, free β-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin. Chem. 38, 370-376.
109. [109] Alfthan, H., Haglund, C., Roberts, P. and Stenman, U.-H. (1992) Elevation of free β subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 52, 4628-4633.
110. [110] Birken, S., Maydelman, Y., Gawinowicz, M.A., Pound, A., Liu, Y.P. and Hartree, A.S. (1996) Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology 137, 1402-1411.
111. [111] Chen, H.-C., Hodgen, G.D., Matsuura, S., Lin, L.J., Gross, E., Reichert, L.E.J., Birken, S., Canfield, R.E. and Ross, G.T. (1976) Evidence for a gonadotropin from nonpregnant subjects that has physiological, immunological, and biological similarities to human chorionic gonadotropin. Proc. Natl. Acad. Sci. USA 73, 2885-2889.
112. [112] Ayala, A.R., Nisula, B.C., Chen, H.-C., Hodgen, G.D. and Ross, G.T. (1978) Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine. J. Clin. Endocrinol. Metab. 47, 767-773.
113. [113] Armstrong, E.G., Ehrlich, P.H., Birken, S., Schlatterer, J.P., Siris, E., Hembree, W.C. and Canfield, R.E. (1984) Use of a highly sensitive and specific immunoradiometric assay for detection of human chorionic gonadotropin in urine of normal, nonpregnant, and pregnant individuals. J. Clin. Endocrinol. Metab. 59, 867-874.
114. [114] Berger, P., Klieber, R., Panmoung, W., Madersbacher, S., Wolf, H. and Wick, G. (1990) Monoclonal antibodies against free subunits of human chorionic gonadotropin. J. Endocrinol. 125, 301-309.
115. [115] Landy, H., Schneyer, A.L., Whitcomb, R.W. and Crowley, W.F. (1990) Validation of highly specific and sensitive radioimmunoassays for lutropin, follitropin, and free alpha subunit in unextracted urine. Clin. Chem. 36, 340-344.
116. [116] Iles, R.K., Lee, C.L., Howes, I., Davies, S., Edwards, R. and Chard, T. (1991) Immunoreactive β-core-like material in normal postmenopausal urine: human chorionic gonadotrophin or LH origin? Evidence for the existence of LH core. J. Endocrinol. 133, 459-466.
117. [117] Neven, P., Iles, R.K., Howes, I., Sharma, K., Shepherd, J.H., Edwards, R., Collins, W.P. and Chard, T. (1993) Substantial urinary concentrations of material resembling β-core fragment of chorionic gonadotropin β-subunit in mid-menstrual cycle. Clin. Chem. 39, 1857-1860.
118. [118] Bagshawe, K.D. (1992) Choriocarcinoma. A model for tumor markers. Acta Oncol. 31, 99-106.
119. [119] Hobson, B. and Wide, L. (1968) Human chorionic gonadotrophin excretion in men and women with invasive trophoblast assayed by an immunological and biological method. Acta Endocrinol, 58, 473-480.
120. [120] Gaspard, U.J., Reuter, A.M., Deville, J.-L., Vrindts-Gevaert, Y., Bagshawe, K.D. and Franchimont, P. (1980) Serum concentrations of human chorionic gonadotropin and its alpha and beta subunits. 2. Trophoblastic tumors. Clin. Endocrinol. 13. 319-329.
121. [121] Ozturk, M., Berkowitz, R., Goldstein, D., Bellet, D. and Wands, J.R. (1988) Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am. J. Obstet. Gynecol. 158, 193-198.
122. [122] Khazaeli, M.B., Hedayat, M.M., Hatch, K.D., To, A.C.W., Soong, S.-J., Shingleton, H.M., Boots, L.R. and LoBuglio, A.F. (1986) Radioimmunoassay of free β-subunit of human chorionic gonadotropin as a prognostic test for persisitent trophoblastic disease in molar pregnancy. Am. J. Obstet. Gynecol. 155, 320-324.
123. [123] Hay, D.L. (1988) Histological origins of discordant chorionic gonadotropin secretion in malignancy. J. Clin. Endocrinol. Metab. 66, 557-564.
124. [124] Berkowitz, R., Ozturk, M., Goldstein, D., Bernstein, M., Hill, L. and Wands, J.R. (1989) Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet. Gynecol. 74, 212-216.
125. [125] Stenman, U.-H., Alfthan, H. and Halila, H. (1985) Determination of chorionic gonadotropin in serum of nonpregnant subjects and patients with trophoblastic cancer by time-resolved immunofluorometric assay. Tumor Biol. 5, 97.
126. [126] Fan, C., Goto, S., Furuhashi, Y. and Tomoda, Y. (1987) Radioimmunoassay of the free β-subunit of human chorionic gonadotropin in trophoblastic disease. J. Clin. Endocrinol. Metab, 64, 313-318.
127. [127] Khazaeli, M.B., Buchina, E.S., Pattillo, R.A., Soong, S.-J. and Hatch, K.D. (1989) Radioimmunoassay of the free β-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease. Am. J. Obstet. Gynecol. 160, 444-449.
128. [128] Vaitukaitis, J.L. and Ebersole, E.R. (1975) Evidence for altered synthesis of human chorionic gonadotropin in gestational trophoblastic tumors. J. Clin. Endocrinol. Metab. 42, 1048-1055.
129. [129] Bidart, J.-M., Troalen, F., Lazar, V., Berger, P., Marcillac, I., Lhomme, C., Droz, J.-P. and Bellet, D. (1992) Monoclonal antibodies to the free β-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules. Endocrinology 131, 1832-1840.
130. [130] Peake, G.T., Buckman, M.T., Davis, L.E. and Standefer, J. (1983) Pituitary and placentally derived hormones in cerebrospinal fluid during normal human pregnancy. J. Clin. Endocrinol. Metab. 56, 46-52.
131. [131] Bagshawe, K.D. (1984) Clinical applications of hCG. Adv. Exp. Med. Biol. 176, 313-324.
132. [132] Braunstein, G.D., Vaitukaitis, J.L., Carbone, P.P. and Ross, G.T. (1973) Ectopic production of human chorionic gonadotrophin by nedplasms. Ann. Intern. Med. 78, 39-45.
133. [133] Mann, K. and Karl, H.-J. (1983) Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer. Cancer 52, 654-660.
134. [134] Norman, R.J., Lowings, C., Oliver, T. and Chard, T. (1985) Human chorionic gonadotrophin and subunits - heterogeneity in serum of male patients with tumours of the genital tract. Clin. Endocrinol. 23, 25-34.
135. [135] Saller, B., Clara, R., Spöttl, G., Siddle, K. and Mann, K. (1990) Testicular cancer secretes intact human choriogonadotropin (hCG) and its free β-subunit: evidence that hCG ( + hCG-β) assays are the most reliable in diagnosis and follow-up. Clin. Chem. 36, 234-239.
136. [136] Marcillac, I., Troalen, F., Bidart, J.-M., Ghillani, P., Ribrag, V., Escudier, B., Malassagne, B., Droz, J.-P., Lhommé, C., Rougier, P., Duvillard, P., Prade, M., Lugagne, P.-M., Richard, F., Poynard, T., Bohuon, C., Wands, J. and Bellet, D. (1992) Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasms. Cancer Res. 52, 3901-3907.
137. [137] Light, P.A., Foster, J.P., Felton, T., Eckert, H. and Tovey, K.C. (1983) Molecular heterogeneity of chorionic gonadotropin in some testicular cancer patients. Lancet, 1284.
138. [138] Fusco, F.D. and Rosen, S.W. (1966) Gonadotropin-producing anaplastic large-cell carcinomas of the lung. N. Engl. J. Med. 275, 507-515.
139. [139] Faiman, C., Colwell, J.A., Ryan, R.J., Hershman, J.M. and Shields, T.W. (1967) Gonadotropin secretion from a bronchogenic carcinoma. N. Engl. J. Med. 277, 1395-1399.
140. [140] Weintraub, B.D. and Rosen, S.W. (1973) Ectopic production of isolated beta subunit of human chorionic gonadotropin. J. Clin. Invest. 52, 3135-3142.
141. [141] Gailani, S., Chu, T.M., Nussbaum, A., Ostrander, M. and Christoff, N. (1976) Human chorionic gonadotrophins (hCG) in nontrophoblstic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestice neoplasms. Cancer 38, 1684-1686.
142. [142] Franchimont, P., Zangerle, P.F., Nogarede, J., Bury, J., Molter, F., Reuter, A., Hendrick, J.C. and Collette, J. (1976) Simultaneous assays of cancer-associated antigens in various neoplastic disorders. Cancer 38, 2287-2295.
143. [143] Hattori, M., Fukase, M., Yoshimi, H., Matsukura, S. and Imura, H. (1978) Ectopic production of human chorionic gonadotropin in malignant tumors. Cancer 42, 2328-2333.
144. [144] Gropp, C., Havemann, K. and Scheuer, A. (1980) Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer 46, 347-354.
145. [145] Recchione, C., Galante, E., Secreto, G., Cavalleri, A. and Dati, V. (1983) Abnormal serum hormone levels in lung cancer. Tumori 69, 293-298.
146. [146] Borkowski, A., Puttaert, V., Gyling, M., Muquardt, C. and Body, J.J. (1984) Human chorionic gonadotropin-like substance in plasma of normal nonpregnant subjects and women with breast cancer. J. Clin. Endocrinol. Metab. 58, 1171-1178.
147. [147] Monteiro, J.C.M.P., Ferguson, K.M., McKinna, A., Greening, W.P. and Neville, A.M. (1984) Ectopic production of human chorionic gonadotropin-like material in breast cancer. Cancer 53, 957-962.
148. [148] Rutanen, E.-M. and Seppälä, M. (1978) The hCG-beta subunit radioimmunoassay in nontrophoblastic gynecological tumors. Cancer 41, 692-696.
149. [149] Carenza, L., di Gregorio, R., Mocci, C., Moro, M. and Pala, A. (1980) Ectopic human chorionic gonadotropin: gynecological tumors and nonmalignant conditions. Gynecol. Oncol. 10, 32-39.
150. [150] Donaldson, E.S., van Nagell, J.R., Pursell, S., Gay, E.C., Meeker, W.R., Kashmiri, R. and van deVoorde, J. (1980) Multiple biochemical markers in patients with gynecological malignancies. Cancer 45, 948-953.
151. [151] Cauchi, M.N., Koh, S.H., Lim, D. and Hay, D.L. (1981) Oncofetal antigens in cancer of the cervix and ovary. Br. J. Cancer 44, 403-409.
152. [152] Cole, L.A., Wang, Y., Elliot, M., Latif, M., Chambers, J.T., Chambers, S.K. and Schwartz, P.E. (1988) Urinary human chorionic gonadotropin free β-subunit and β-core fragment: a new marker of gynecological cancers. Cancer Res. 48, 1356-1360.
153. [153] Norman, R.J., Buck, R.H., Aktar, B., Mayet, N. and Moodley, J. (1990) Detection of a small molecular species of human chorionic gonadotropin in the urine of patients with carcinoma of the cervix and cervical intraepithelial neoplasia; comparison with other assays for human chorionic gonadotropin and its fragments. Gynecol. Oncol. 37, 254-259.
154. [154] Papapetrou, P.D., Sakarelou, N.P., Braouzi, H. and Fessas, P.H. (1980) Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: The value of measurements of immunoreactive hCG in the urine as a screening procedure. Cancer 45, 2583-2592.
155. [155] Fukutani, K., Libby, J.M., Panko, W.B. and Scardino, P.T. (1983) Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney. J. Urol. 129, 74-77.
156. [156] Iles, R.K., Jenkins, B.J., Oliver, R.T., Blandy, J.P. and Chard, T. (1989) Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br. J. Urol. 64, 241-244.
157. [157] Lee, C.L., Iles, R.K., Shepherd, J.H., Hudson, C.N. and Chard, T. (1991) The purification and development of a radioimmunoassay for β-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. J. Endocrinol. 130, 481-489.
158. [158] O'Connor, J.F., Schlatterer, J.P., Birken, S., Krichevsky, A., Armstrong, E.G., McMahon, D. and Canfield, R.E. (1988) Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its β-subunit, and β core fragment in the urine: Application to malignancies. Cancer Res. 48, 1361-1366.
159. [159] Nam, J.-H., Cole, L.A., Chambers, J.T. and Schwartz, P.E. (1990) Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity. Gynecol. Oncol. 36, 383-390.
160. [160] Wang, Y., Schwartz, P.E., Chambers, J.T. and Cole, L.A. (1988) Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies. Gynecol. Oncol. 31, 91-100.
161. [161] Carter, P.G., Iles, R.K., Neven, P., Ind, T.E.J., Shepherd, J.H. and Chard, T. (1994) The prognostic significance of urinary β cor fragment in premenopausal women with carcinoma of the cervix. Gynecol. Oncol. 55, 271-276.
162. [162] Carter, P.G., Iles, R.K., Neven, P., Ind, T.E.J., Shepherd, J.H. and Chard, T. (1995) Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvo-vaginal malignancy and its prognostic significance. Br. J. Cancer. 71, 350-353.
163. [163] Iles, R.K., Lee, C.L., Oliver, R.T. and Chard, T. (1990) Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder. Clin. Endocrinol. 33, 355-364.
164. [164] Iles, R.K., Purkis, P.E., Whitehead, P.C., Oliver, R.T.D., Leigh, I. and Chard, T. (1990) Expression of beta human chorionic gonadotropin by nontrophoblastic non-endocrine 'normal' and malignant epithelial cells. Br. J. Cancer. 61, 663-666.
165. [165] Ozturk, M., Bellet, D., Isselbacher, K.J. and Wands, J. (1987) Ectopic β-human chorionic gonadotropin production by a human hepatoma cell line (FOCUS): Isolation and immunochemical characterization. Endocrinology 120, 559-566.
166. [166] Nishimura, R., Koizumi, T., Morisue, K., Yamanaka, N., Lalwani, R., Yoshimura, M., Nakagawa, T., Shii, K., Hasegawa, K. and Baba, S. (1995) Expression and secretion of the β subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro. Cancer Res. 55, 1479-1484.
167. [167] Goldstein, S., Jones, R.A., Hardin, J.W., Braunstein, G.D. and Shmookler Reis, R.J. (1990) Expression of α- and β-human chorionic gonadotropin subunits in cultured human cells. In Vitro Cell. Dev. Biol. 26, 857-864.
168. [168] Braunstein, G.D., Forsythe, A.B., Rasor, J.L., van Scoy-Mosher, M.B., Thompson, R.W. and Wade, M.E. (1979) Serum glycoprotein hormone alpha subunit levels in patients with cancer. Cancer 44, 1644-1651.
169. [169] Rosen, S.W. and Weintraub, B.D. (1974) Ectopic production of isolated alpha subunits of the glycoprotein hormones. N. Engl. J. Med. 290, 1441-1447.
170. [170] Kahn, C.R., Rosen, S.W., Weintraub, B.D., Fajans, S.S. and Gorden, P. (1977) Ectopic production of chorionic gonadotrophin and its subunits by islet cell tumors; a specific marker for malignancy. N. Engl. J. Med. 297, 565-569.
171. [171] Öberg, K. and Wide, L. (1981) hCG and hCG subunits as tumour markers in patients with endcocrine pancreatic tumours and carcinoids. Acta Endocrinol. 98, 256-260.
172. [172] Ridgway, E.C., Klibanski, A., Ladenson, P.W., Clemmons, D., Beitins, I.Z., McArthur, J.W., Martorana, M.A. and Zervas, N.T. (1981) Pure alphasecreting pituitary adenomas. N. Engl. J. Med. 304, 1254-1259.